MycroDose Therapeutics: Funding, Investors & Team (Oct 2026)
Mycrodose Therapeutics is a US-Based pharmaceutical company specialized in the development of advanced drug delivery (ADD) systems utilizing psychedelic compounds to treat mental health and cognitive degenerative diseases. The company is in the parallel development of two of its four core technologies; a psilocybin transdermal delivery system, Ketamine oral mucosa delivery system.
MycroDose Therapeutics has raised $100k across 1 funding round on record, the most recent a Seed of $100k announced in Sep 2021.
That round is below the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
MycroDose Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2021.
MycroDose Therapeutics Funding Rounds
MycroDose Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
MycroDose Therapeutics Funding Compared to Other Health Care Startups
MycroDose Therapeutics' latest round of $100k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MycroDose Therapeutics in Health Care and San Diego
Companies Similar to MycroDose Therapeutics
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
MycroDose Therapeutics Funding FAQs
What does MycroDose Therapeutics do?
Mycrodose Therapeutics is a US-Based pharmaceutical company specialized in the development of advanced drug delivery (ADD) systems utilizing psychedelic compounds to treat mental health and cognitive degenerative diseases. The company is in the parallel development of two of its four core technologies; a psilocybin transdermal delivery system, Ketamine oral mucosa delivery system.
How much funding has MycroDose Therapeutics raised?
MycroDose Therapeutics has raised $100k across 1 round on record. The most recent is a Seed of $100k announced in Sep 2021.
When did MycroDose Therapeutics last raise funding?
MycroDose Therapeutics' most recent funding round on record is a Seed of $100k, announced in Sep 2021.
Who is the CEO of MycroDose Therapeutics?
Chad Conner is listed as CEO at MycroDose Therapeutics.
Where is MycroDose Therapeutics headquartered?
MycroDose Therapeutics is based in San Diego, California, United States.
How many employees does MycroDose Therapeutics have?
MycroDose Therapeutics is in the 1-10 employee band.
How does MycroDose Therapeutics' funding compare to other Health Care startups?
MycroDose Therapeutics' latest round of $100k is below the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's MycroDose Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MycroDose Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.